Invitrogen™ CDR2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA146001

Catalog No. 01-674-579

Description

This antibody shares 85% sequence homology with rat. Suggested positive control: Hela whole cell extract, antigen standard for CDR2 (transient overexpression lysate).

Using anti-Yo antibodies, three genes have been cloned (CDR 1-3). CDR2 suppresses the transcriptional activity and DNA binding of nuclear factor-kappa B by an unknown mechanism. The neuron specific expression of CDR2 is regulated by a post-transcriptional mechanism.

Specifications

• Antigen: CDR2
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: CDR2
• Gene Alias: AA617262; CDR2; CDR62; cerebellar degeneration related protein 2; cerebellar degeneration-related 2; cerebellar degeneration-related protein 2; cerebellar degeneration-related protein 2, 62kDa; major Yo paraneoplastic antigen; MGC128861 protein; paraneoplastic cerebellar degeneration-associated antigen; PCD17; RGD1310578; Yo; Yo paraneoplastic antigen
• Host Species: Rabbit
• Purification Method: Antigen affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 1039, 12585, 534647
• Content And Storage: 4°C, do not freeze
• Form: Liquid

• Applications: Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
• Concentration: 1 mg/mL
• Formulation: phosphate, tris citrate with 0.1% sodium azide; pH 7-8
• Gene Accession No.: P97817, Q01850
• Gene Symbols: CDR2
• Immunogen: Synthetic peptide made to a C-terminal region of the human CDR2 protein.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse, Monkey, Bovine
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov